195 related articles for article (PubMed ID: 10359017)
1. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.
Horrobin DF; Bennett CN
Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):141-67. PubMed ID: 10359017
[TBL] [Abstract][Full Text] [Related]
2. Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: an update.
Bennett CN; Horrobin DF
Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):47-59. PubMed ID: 10970713
[TBL] [Abstract][Full Text] [Related]
3. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.
Horrobin DF; Bennett CN
Prostaglandins Leukot Essent Fatty Acids; 1999 Apr; 60(4):217-34. PubMed ID: 10397403
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum.
Richardson AJ; Ross MA
Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):1-9. PubMed ID: 10970706
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
6. Folate and long-chain polyunsaturated fatty acids in psychiatric disease.
Muskiet FA; Kemperman RF
J Nutr Biochem; 2006 Nov; 17(11):717-27. PubMed ID: 16650750
[TBL] [Abstract][Full Text] [Related]
7. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.
Nemeroff CB; Bissette G
Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745
[TBL] [Abstract][Full Text] [Related]
8. [Mental disease a heritage. New genetic knowledge can reveal "public diseases" such as autism, dyslexia, alcoholism, anorexia, schizophrenia].
Wetterberg L
Lakartidningen; 2000 Feb; 97(6):558-62, 565-7. PubMed ID: 10707480
[TBL] [Abstract][Full Text] [Related]
9. Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders.
Ward PE
Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):65-8. PubMed ID: 10970715
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and psychiatric disorders.
Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
12. Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia.
Horrobin DF; Glen AI; Hudson CJ
Med Hypotheses; 1995 Dec; 45(6):605-13. PubMed ID: 8771057
[TBL] [Abstract][Full Text] [Related]
13. Genetics of affective (mood) disorders.
Craddock N; Forty L
Eur J Hum Genet; 2006 Jun; 14(6):660-8. PubMed ID: 16721402
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the genetic background of bipolar disorder and schizophrenia (introduction)].
Gábor G
Neuropsychopharmacol Hung; 2007 Jun; 9(2):77-9. PubMed ID: 17970530
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism.
Ross BM
Med Hypotheses; 2007; 68(3):515-24. PubMed ID: 17045757
[TBL] [Abstract][Full Text] [Related]
16. Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment.
Walker J; Curtis V; Murray RM
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S11-9. PubMed ID: 12570067
[TBL] [Abstract][Full Text] [Related]
17. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
Kim H; McGrath BM; Silverstone PH
Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
[TBL] [Abstract][Full Text] [Related]
18. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
Puri BK
Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
[TBL] [Abstract][Full Text] [Related]
19. Essential fatty acids and psychiatric disorders.
Perica MM; Delas I
Nutr Clin Pract; 2011 Aug; 26(4):409-25. PubMed ID: 21775637
[TBL] [Abstract][Full Text] [Related]
20. Visual function, fatty acids and dyslexia.
Taylor KE; Richardson AJ
Prostaglandins Leukot Essent Fatty Acids; 2000; 63(1-2):89-93. PubMed ID: 10970719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
